Work

Abstract 1143: Enspyre: A novel enrichment technology enables ultra-sensitive ctDNA detection with 98% reduction in sequencing requirements

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-1143

Authors: Paul Labrousse, Sophie Hackinger, Hugh Russell, Daniel Stetson, David Shera, Paulina Powalowska-Picton, Katarzyna Anton, Maria Litovchenko, Ernesto Lowy-Gallego, Amy Lovell, Magdalena Stolarek-Januszkiewicz, Barnaby Balmforth, James Hadfield

Institutions: AstraZeneca (United States), AstraZeneca (United Kingdom)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148652749

Cites:

Cited by:

Related to: